Multi-functional echogenic immunoliposomes for directed stem cell delivery to atheroma
US10639277B1 · kind B1 · utility
0Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 2, 2018 |
| Grant date | May 5, 2020 |
| Priority date | — |
| Expiry date | May 10, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/5047
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are multifunctional-echogenic immunoliposome (MF-ELIP) constructs and compositions, and their methods of use to deliver attached stem cells to a target tissue such as atheroma, to enhance one or more of survival, growth, migration, activity and differentiation of the targeted stem cells, for treating, deterring or preventing mammalian atheroma and coronary artery disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.